Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
Aldeyra Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 27, 2020
Aldeyra Therapeutics reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, three executives at Aldeyra Therapeutics received on average a compensation package of $2.8M, a 69% increase compared to previous year.
Average pay of disclosed executives at Aldeyra Therapeutics
Todd C. Brady, Chief Executive Officer, received $4.1M in total, which increased by 44% compared to 2018. 49% of Brady's compensation, or $2M, was in stock awards. Brady also received $235K in non-equity incentive plan, $1.4M in option awards, $523K in salary, as well as $11K in other compensation.
Joshua Reed, Chief Financial Officer, received a compensation package of $2.2M. 62% of the compensation package, or $1.4M, was in option awards.
David J. Clark, Chief Medical Officer, earned $2M in 2019, a 64% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2020.